Novel modulators of cortical dopaminergic- and nmda-receptor-mediated glutamatergic neurotransmission
AssigneeIntegrative Research Laboratories Sweden AB
InventorsClas SONESSON, Jonas KARLSSON, Peder SVENSSON
Life of this patent
Estimating the term…
Abstract
The present invention relates to novel substituted phenoxyethylamine derivatives, useful as modulators of cortical and basal ganglia dopaminergic and N-methyl-D-aspartate (NMDA) receptor-mediated glutamatergic neurotransmission. In other aspects the invention relates to the use of these compounds in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention.
Claims20
A phenoxy-ethyl-amine derivative, wherein the phenoxy-ethyl-amine derivative is N-[2-(3-fluoro-5-methylsulfonyl-phenoxy)ethyl]propan-1-amine, or a pharmaceutically acceptable salt thereof.
A phenoxy-ethyl-amine derivative, wherein the phenoxy-ethyl-amine derivative is N-[2-(3-fluoro-5-methylsulfonyl-phenoxy)ethyl]butan-1-amine, or a pharmaceutically acceptable salt thereof.
A phenoxy-ethyl-amine derivative, wherein the phenoxy-ethyl-amine derivative is N-ethyl-2-(3-fluoro-5-methylsulfonyl-phenoxy)ethanamine, or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.